167 related articles for article (PubMed ID: 23020131)
21. c-Jun NH2-terminal kinase-mediated up-regulation of death receptor 5 contributes to induction of apoptosis by the novel synthetic triterpenoid methyl-2-cyano-3,12-dioxooleana-1, 9-dien-28-oate in human lung cancer cells.
Zou W; Liu X; Yue P; Zhou Z; Sporn MB; Lotan R; Khuri FR; Sun SY
Cancer Res; 2004 Oct; 64(20):7570-8. PubMed ID: 15492284
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activity.
Deeb D; Gao X; Liu Y; Kim SH; Pindolia KR; Arbab AS; Gautam SC
Biochem Biophys Res Commun; 2012 Jun; 422(4):561-7. PubMed ID: 22609405
[TBL] [Abstract][Full Text] [Related]
23. CDDO-Me, a synthetic triterpenoid, inhibits expression of IL-6 and Stat3 phosphorylation in multi-drug resistant ovarian cancer cells.
Duan Z; Ames RY; Ryan M; Hornicek FJ; Mankin H; Seiden MV
Cancer Chemother Pharmacol; 2009 Mar; 63(4):681-9. PubMed ID: 18587580
[TBL] [Abstract][Full Text] [Related]
24. CDDO-Me reveals USP7 as a novel target in ovarian cancer cells.
Qin D; Wang W; Lei H; Luo H; Cai H; Tang C; Wu Y; Wang Y; Jin J; Xiao W; Wang T; Ma C; Xu H; Zhang J; Gao F; Wu YL
Oncotarget; 2016 Nov; 7(47):77096-77109. PubMed ID: 27780924
[TBL] [Abstract][Full Text] [Related]
25. Dimethyl fumarate and the oleanane triterpenoids, CDDO-imidazolide and CDDO-methyl ester, both activate the Nrf2 pathway but have opposite effects in the A/J model of lung carcinogenesis.
To C; Ringelberg CS; Royce DB; Williams CR; Risingsong R; Sporn MB; Liby KT
Carcinogenesis; 2015 Jul; 36(7):769-81. PubMed ID: 25939751
[TBL] [Abstract][Full Text] [Related]
26. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
Chintharlapalli S; Papineni S; Konopleva M; Andreef M; Samudio I; Safe S
Mol Pharmacol; 2005 Jul; 68(1):119-28. PubMed ID: 15798084
[TBL] [Abstract][Full Text] [Related]
27. The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
Li M; Sun K; Redelman D; Welniak LA; Murphy WJ
Biol Blood Marrow Transplant; 2010 Jun; 16(6):739-50. PubMed ID: 20338256
[TBL] [Abstract][Full Text] [Related]
28. Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.
Konopleva M; Tsao T; Ruvolo P; Stiouf I; Estrov Z; Leysath CE; Zhao S; Harris D; Chang S; Jackson CE; Munsell M; Suh N; Gribble G; Honda T; May WS; Sporn MB; Andreeff M
Blood; 2002 Jan; 99(1):326-35. PubMed ID: 11756188
[TBL] [Abstract][Full Text] [Related]
29. Oleanane triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells through a ROS-dependent mechanism.
Deeb D; Gao X; Jiang H; Janic B; Arbab AS; Rojanasakul Y; Dulchavsky SA; Gautam SC
Biochem Pharmacol; 2010 Feb; 79(3):350-60. PubMed ID: 19782051
[TBL] [Abstract][Full Text] [Related]
30. Identification of a novel synthetic triterpenoid, methyl-2-cyano-3,12-dioxooleana-1,9-dien-28-oate, that potently induces caspase-mediated apoptosis in human lung cancer cells.
Kim KB; Lotan R; Yue P; Sporn MB; Suh N; Gribble GW; Honda T; Wu GS; Hong WK; Sun SY
Mol Cancer Ther; 2002 Jan; 1(3):177-84. PubMed ID: 12467212
[TBL] [Abstract][Full Text] [Related]
31. CDDO-Me protects normal lung and breast epithelial cells but not cancer cells from radiation.
El-Ashmawy M; Delgado O; Cardentey A; Wright WE; Shay JW
PLoS One; 2014; 9(12):e115600. PubMed ID: 25536195
[TBL] [Abstract][Full Text] [Related]
32. Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation.
Zou W; Yue P; Khuri FR; Sun SY
Cancer Res; 2008 Sep; 68(18):7484-92. PubMed ID: 18794136
[TBL] [Abstract][Full Text] [Related]
33. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
34. Role of reactive oxygen species (ROS) in CDDO-Me-mediated growth inhibition and apoptosis in colorectal cancer cells.
Gao X; Deeb D; Liu P; Liu Y; Arbab-Ali S; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2011; 9(2):119-27. PubMed ID: 21699019
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids.
Borella R; Forti L; Gibellini L; De Gaetano A; De Biasi S; Nasi M; Cossarizza A; Pinti M
Molecules; 2019 Nov; 24(22):. PubMed ID: 31766211
[TBL] [Abstract][Full Text] [Related]
36. The novel triterpenoid C-28 methyl ester of 2-cyano-3, 12-dioxoolen-1, 9-dien-28-oic acid inhibits metastatic murine breast tumor growth through inactivation of STAT3 signaling.
Ling X; Konopleva M; Zeng Z; Ruvolo V; Stephens LC; Schober W; McQueen T; Dietrich M; Madden TL; Andreeff M
Cancer Res; 2007 May; 67(9):4210-8. PubMed ID: 17483332
[TBL] [Abstract][Full Text] [Related]
37. Methyl 2-cyano-3,12-dioxooleana-1,9-dien-28-oate decreases specificity protein transcription factors and inhibits pancreatic tumor growth: role of microRNA-27a.
Jutooru I; Chadalapaka G; Abdelrahim M; Basha MR; Samudio I; Konopleva M; Andreeff M; Safe S
Mol Pharmacol; 2010 Aug; 78(2):226-36. PubMed ID: 20488920
[TBL] [Abstract][Full Text] [Related]
38. CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages.
Ball MS; Shipman EP; Kim H; Liby KT; Pioli PA
PLoS One; 2016; 11(2):e0149600. PubMed ID: 26918785
[TBL] [Abstract][Full Text] [Related]
39. c-FLIP downregulation contributes to apoptosis induction by the novel synthetic triterpenoid methyl-2-cyano-3, 12-dioxooleana-1, 9-dien-28-oate (CDDO-Me) in human lung cancer cells.
Zou W; Chen S; Liu X; Yue P; Sporn MB; Khuri FR; Sun SY
Cancer Biol Ther; 2007 Oct; 6(10):1614-20. PubMed ID: 18253090
[TBL] [Abstract][Full Text] [Related]
40. The novel triterpenoid CDDO-Me suppresses MAPK pathways and promotes p38 activation in acute myeloid leukemia cells.
Konopleva M; Contractor R; Kurinna SM; Chen W; Andreeff M; Ruvolo PP
Leukemia; 2005 Aug; 19(8):1350-4. PubMed ID: 15931262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]